Similar articles

• Preliminary report on the effect of brachytherapy on expression of p53, bc1-2 and apoptosis in squamous cell carcinoma of the oesophagus.

  Sur M, Sur RK, Cooper K, Bizos D. Sur M, et al. S Afr J Surg. 2003 Feb;41(1):14-20. S Afr J Surg. 2003. PMID: 12756868 Clinical Trial.
• [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].

  Shiozaki H, Yano M. Shiozaki H, et al. Nihon Geka Gakkai Zasshi. 2002 Mar;103(3):284-9. Nihon Geka Gakkai Zasshi. 2002. PMID: 11968758 Review. Japanese.
• Oesophageal cancer in Africa.

  Hendricks D, Parker MI. Hendricks D, et al. IUBMB Life. 2002 Apr-May;53(4-5):263-8. doi: 10.1080/15216540212643. IUBMB Life. 2002. PMID: 12121007 Review.
• Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.

  Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T, Zhang ZF. Cao W, et al. Cancer. 2004 Aug 15;101(4):834-44. doi: 10.1002/cncr.20437. Cancer. 2004. PMID: 15305417
• p53 mutations in human papillomavirus-associated oesophageal squamous cell carcinoma.

  Cooper K. Cooper K. Br J Cancer. 1995 Nov;72(5):1337. doi: 10.1038/bjc.1995.511. Br J Cancer. 1995. PMID: 7577493 Free PMC article. No abstract available.